A Study of LY3454738 in Healthy Participants and Participants With Atopic Dermatitis

Summary

The main purpose of this study is to investigate the safety, tolerability, and efficacy of the study drug known as LY3454738 in healthy participants and participants with atopic dermatitis. The study has three parts. Each participant will enroll in one part. The study will last 12 to 24 weeks, depending on part.

Timeline

Start

2018-11-29

Primary completion

2021-09-07

Completion

2021-09-07

Drugs

Indications